Preferred Label : Fulvestrant;
MeSH definition : An estradiol derivative and estrogen receptor antagonist that is used for the treatment
of estrogen receptor-positive, locally advanced or metastatic breast cancer.;
MeSH synonym : 7-(9-(4,4,5,5,5-pentafluoropentylsulfinyl)nonyl)estra-1,3,5(10)-triene-3,17-diol;
MeSH hyponym : ICI 182,780; ICI-182780; ICI182780; ZM-182780; ZM182780;
MeSH Related Number : 129453-61-8 (Fulvestrant);
UNII : 22X328QOC4;
Origin ID : D000077267;
UMLS CUI : C0935916;
ATC code(s)
- Allowable qualifiers
- MeSH indexing information
- Pharmacological action(s)
- Record concept(s)
- See also inter- (CISMeF)
- Semantic type(s)
- UMLS correspondences (same concept)
- Validated automatic mappings to BTNT
An estradiol derivative and estrogen receptor antagonist that is used for the treatment
of estrogen receptor-positive, locally advanced or metastatic breast cancer.
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=63572534
2021
false
false
false
France
French
Fulvestrant
injections, intramuscular
summary of product characteristics
package leaflet
antineoplastic agents, hormonal
estrogen antagonists
fulvestrant
---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=60446306
2021
false
false
false
France
French
Fulvestrant
injections, intramuscular
fulvestrant
summary of product characteristics
package leaflet
antineoplastic agents, hormonal
estrogen antagonists
---
https://www.has-sante.fr/jcms/p_3181664/fr/fulvestrant-mylan
2020
false
false
false
France
fulvestrant
antineoplastic combined chemotherapy protocols
antineoplastic agents, hormonal
treatment outcome
postmenopause
breast neoplasms
neoplasm metastasis
Hormone receptor positive malignant neoplasm of breast (disorder)
hormone-receptor-positive, HER2-negative locally advanced or metastatic breast cancer
evaluation of the transparency committee
Fulvestrant
---
https://www.has-sante.fr/jcms/p_3201259/fr/fulvestrant-accord
2020
false
false
false
France
fulvestrant
drugs, generic
evaluation of the transparency committee
Fulvestrant
---
https://www.has-sante.fr/portail/jcms/c_2964744/fr/faslodex
2019
false
false
false
France
Fulvestrant
fulvestrant
injections, intramuscular
treatment outcome
antineoplastic agents, hormonal
estrogen receptor positive breast cancer
breast neoplasms
postmenopause
antineoplastic combined chemotherapy protocols
neoplasm metastasis
Hormone receptor positive malignant neoplasm of breast (disorder)
palbociclib
evaluation of the transparency committee
piperazines
pyridines
---
https://www.has-sante.fr/portail/jcms/c_2867425/fr/fulvestrant-teva
2018
false
false
false
false
France
French
evaluation of the transparency committee
drugs, generic
fulvestrant
estradiol
Fulvestrant
---
https://www.ema.europa.eu/medicines/human/EPAR/Fulvestrant-Mylan
2018
false
United Kingdom
English
French
syndication feed
treatment outcome
drugs, generic
Locally Advanced Malignant Neoplasm
postmenopause
Stage IV Breast Cancer AJCC v6 and v7
Oestrogen receptor positive breast cancer
estrogen antagonists
antineoplastic agents, hormonal
breast neoplasms
neoplasm metastasis
antineoplastic agents, hormonal
estrogen antagonists
neoplasm recurrence, local
fulvestrant
injections, intramuscular
package leaflet
summary of product characteristics
Fulvestrant
Fulvestrant
---
FASLODEX (fulvestrant) - Risk of Unnecessary Therapy Modification due to Falsely Elevated
Estradiol Levels
http://canadiensensante.gc.ca/recall-alert-rappel-avis/hc-sc/2016/60590a-fra.php
2016
false
false
false
Canada
French
English
pharmacovigilance note
estradiol
breast neoplasms
antineoplastic agents, hormonal
breast neoplasms
menopause
radioimmunoassay
false positive reactions
fulvestrant
Fulvestrant
---
https://www.ema.europa.eu/medicines/human/EPAR/Faslodex
2012
false
United Kingdom
English
French
syndication feed
estrogen antagonists
antineoplastic agents, hormonal
breast neoplasms
neoplasm metastasis
antineoplastic agents, hormonal
estrogen antagonists
recurrence
fulvestrant
injections, intramuscular
drug evaluation
package leaflet
summary of product characteristics
Fulvestrant
Fulvestrant
---
http://www.has-sante.fr/portail/jcms/c_987198/faslodex
http://www.has-sante.fr/portail/upload/docs/application/pdf/2010-10/faslodex_-_ct-7666.pdf
2010
false
France
French
injections, intramuscular
fulvestrant
insurance, health, reimbursement
antineoplastic agents, hormonal
estrogen antagonists
breast neoplasms
neoplasm recurrence, local
postmenopause
evaluation of the transparency committee
Fulvestrant
---
https://www.jle.com/fr/revues/medecine/bdc/e-docs/00/04/4C/03/resume.phtml
2009
false
France
French
breast neoplasms
antineoplastic agents, hormonal
journal article
Fulvestrant
---
